Feature Dipexium aims to have first topical antibiotic approved for DFI By Len Zehr Dipexium (NASDAQ:DPRX) is enrolling patients in two pivotal Phase 3 trials of its Locilex topical antibiotic in what it hopes will be the first FDA-approved antibiotic topical cream for the treatment of mild... September 2, 2014